Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. It offers pharmaceutical products in the form of tablets, capsules, liquid orals, external preparations, gel, mouthwash, and lotion; and nutraceutical tablets, capsules, liquids, sachets, oral sprays, and effervescent tablets, as well as ice gels, pastes, solutions, suspension, syrup, cream, drypowders, and toothpastes. The company has strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) regarding the technology transfer of Vorinostat- one of the crucial medications for treating Cutaneous T-Cell Lymphoma (CTCL). The company was incorporated in 2014 and is based in Surat, India.
Metrics to compare | TIDT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTIDTPeersSector | |
---|---|---|---|---|
P/E Ratio | 25.6x | 15.4x | −0.5x | |
PEG Ratio | 0.32 | 0.05 | 0.00 | |
Price/Book | 4.7x | 1.2x | 2.6x | |
Price / LTM Sales | 3.5x | 1.2x | 3.2x | |
Upside (Analyst Target) | - | 0.0% | 42.0% | |
Fair Value Upside | Unlock | 0.3% | 6.6% | Unlock |